Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
09/17/1997 | CN1159755A Use of 2,4-diamino pyrimidine 3-oxide or a salt thereof for treating collagen maturation and structuring disorders |
09/17/1997 | CN1159753A Anti-acne cosmetic compositions |
09/17/1997 | CN1159346A Medicinal decoction for removing freckle |
09/17/1997 | CN1159322A Use of procysteine as depigmenting agent |
09/16/1997 | US5668156 Di (aromatic) compounds and their use in human and veterinary medicine and in cosmetics |
09/16/1997 | US5668152 Protein kinase C inhibitors |
09/16/1997 | US5668129 N-substituted azaheterocyclic carboxylic acids and esters thereof |
09/16/1997 | US5667800 Lotions with lipids and emulsifiers |
09/16/1997 | US5667789 Emulsifier free, cosmetic and dermatological compositions, treatment of acne, aging |
09/16/1997 | US5667769 Process and arrangement for treating hair and the skins of the head and/or body with CO2 |
09/12/1997 | WO1997032882A1 PYRIMIDO[5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION |
09/12/1997 | WO1997032881A1 4-amino pyrimidine derivates, medicaments containing these compounds, their use and process for their production |
09/12/1997 | WO1997032880A1 Pyrimido[5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production |
09/12/1997 | WO1997032865A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
09/12/1997 | WO1997032594A1 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
09/12/1997 | WO1997032562A1 Use of n-aryl-2-hydroxyalkylamides for stimulating or inducing hair growth and/or arresting hair loss |
09/12/1997 | WO1997032561A1 Skin care compositions |
09/12/1997 | WO1997032480A1 A method of killing or inhibiting microbial cells |
09/12/1997 | WO1997022698A3 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
09/12/1997 | CA2248720A1 Pyrimido[5,4-d]pyrimidines, pharmaceuticals containing these compounds, their use and processes for the preparation thereof |
09/12/1997 | CA2248630A1 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
09/12/1997 | CA2248316A1 Pyrimido[5,4-d]pyrimidines, pharmaceuticals containing these compounds, their use and processes for their preparation |
09/12/1997 | CA2248065A1 A method of killing or inhibiting microbial cells |
09/12/1997 | CA2247826A1 Skin care compositions |
09/12/1997 | CA2243994A1 4-amino pyrimidine derivates, medicaments containing these compounds, their use and process for their production |
09/11/1997 | DE19608665A1 Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New Arylglycinamidderivate, processes for their preparation containing these compounds and pharmaceutical compositions |
09/11/1997 | DE19608653A1 Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Pyrimido [5,4-d] pyrimidines, medicaments containing these compounds, their use and process for their preparation |
09/11/1997 | DE19608588A1 Pyrimido [5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Pyrimido [5,4-d] pyrimidines, medicaments containing these compounds, their use and process for their preparation |
09/10/1997 | EP0794258A2 Saccharide composition comprising maltooligosylturanose and maltooligosylparatinose, its preparation and uses |
09/10/1997 | EP0793966A1 Cyclosporin-containing topical pharmaceutical composition |
09/10/1997 | EP0793658A1 Oxazole derivatives as antagonists of alpha-1c adrenergic receptors |
09/10/1997 | EP0793649A1 18,19-dinor-vitamin d compounds |
09/10/1997 | EP0793648A1 18-nor-vitamin d compounds |
09/10/1997 | EP0793489A1 Compositions for the treatment of skin disorders |
09/10/1997 | EP0793476A1 Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof |
09/10/1997 | EP0558635B1 Improved matrix metalloprotease inhibitors |
09/10/1997 | CN1159158A Antibacterial oil-in-water emulsions |
09/10/1997 | CN1158855A Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmacueticals |
09/10/1997 | CN1158733A Preparation of external-use ointment for burn and scald |
09/10/1997 | CN1158732A Aldehyde-olefin scald medicine liquid |
09/10/1997 | CN1158726A Process for making pharmaceutical formulation containing novel steroid esters |
09/10/1997 | CN1158725A Use of 8,9-dehydroestrone as antioxidant |
09/10/1997 | CN1035803C Soluble hemostyptic fabric |
09/09/1997 | US5665870 Method of purifying keratinocyte growth factor (KGF) |
09/09/1997 | US5665778 Ceramides, process for their preparation and their applications in cosmetics and in dermopharmacy |
09/09/1997 | US5665749 For treating inflammation, allergies or cardiovascular diseases in mammals |
09/09/1997 | US5665737 Phosphodiesterase inhibitors |
09/09/1997 | US5665372 Autologous dermal fibroblasts for the repair of skin and soft tissue defects |
09/09/1997 | US5665365 Formulations containing coumarins and the use thereof in the pharmaceutical and cosmetic fields |
09/09/1997 | US5665364 Treating skin disorders such as acne |
09/09/1997 | US5665335 Combinations of vasoactive substances with fatty acids to prevent hair loss |
09/04/1997 | WO1997032046A1 Method and composition for hair removal |
09/04/1997 | WO1997032033A1 Compositions and methods of making embryonic stem cells |
09/04/1997 | WO1997031949A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
09/04/1997 | WO1997031941A2 Soluble tachykinin antagonists, the preparation and use thereof |
09/04/1997 | CA2247802A1 Soluble tachykinin antagonists, the preparation and use thereof |
09/04/1997 | CA2247502A1 Compositions and methods of making embryonic stem cells |
09/03/1997 | EP0792641A1 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
09/03/1997 | EP0792640A2 Use of (E)-1-(4'-(2-alkylaminoethioxy)-phenyl)-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes for inhibiting pathological conditions |
09/03/1997 | EP0792371A1 Combination method for acne treatment |
09/03/1997 | EP0792370A1 INTERLEUKIN-1 $g(b) CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4 |
09/03/1997 | EP0792163A1 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
09/03/1997 | EP0792158A1 Use of angiotensin ii fragments and analogs thereof in tissue repair |
09/03/1997 | EP0792137A1 Antifungal treatment of nails |
09/03/1997 | EP0686026B1 Synergistic combinations of sunscreening substances, cosmetic and dermatological compositions containing such combinations |
09/03/1997 | CN1158567A Compositions for the treatment of skin disorders |
09/03/1997 | CN1158357A Gene regulating aureobasidin sensitivity |
09/03/1997 | CN1158257A Universal injury liquid and its prepn. method |
09/02/1997 | US5663450 Promotes healing |
09/02/1997 | US5663367 Regulator of cell proliferation and differentiation; treatment of skin disorders, antiinflammatory agents, anticarcinogenic agents |
09/02/1997 | US5663347 Regulators of cell proliferation and differentiation; treatment of skin disorders; anticarcinognic agents |
09/02/1997 | US5663345 Immunoregulatory, neuromuscular, joint and connective tissue disorders |
09/02/1997 | US5663334 Process for preparing pyrimidyl imidazoles |
09/02/1997 | US5663208 Pyruvic acid comppounds, antioxidants and fatty acids |
09/02/1997 | US5663160 Cosmetic or dermatological composition containing at least one saponin of the ginsenoside type, and its applications, especially for treating the hair |
09/02/1997 | US5663157 For treating hyperproliferative diseases |
09/02/1997 | US5663070 Recombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TM |
09/02/1997 | US5662927 Sequential adminitration of drugs for estrogen and progesterone and packages |
09/02/1997 | US5662904 Anti-scarring compositions comprising growth factor neutralizing antibodies |
08/28/1997 | WO1997030697A1 Method of treating alopecia |
08/28/1997 | WO1997030691A1 Skin treatment with salicylic acid esters and retinoids |
08/28/1997 | WO1997030680A1 Cosmetic agent with an ilex resin content, process for extraction of ilex resin and ilex resin obtained thereby |
08/28/1997 | WO1997022624A3 Cosmetic preparations containing vertebrate proteins and having antibacterial, antimycotical and antiviral action |
08/28/1997 | WO1997022346A3 Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances |
08/28/1997 | DE19606545A1 Kosmetisches Mittel mit einem Gehalt an Ilexharz, Verfahren zur Gewinnung von Ilexharz und durch dieses Verfahren erhältliches Ilexharz Cosmetic agent containing ilex resin, process for obtaining ilex resin and obtainable by this method Ilex resin |
08/28/1997 | DE19600939C1 Verfahren zur Trennung von IgG und IgA A method for separating IgG and IgA |
08/28/1997 | CA2247258A1 Method of treating alopecia |
08/28/1997 | CA2198571A1 Use of (e)-1-¬4'-(2-alkylaminoethioxy)phenyl|-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions |
08/27/1997 | EP0791651A1 Method for the treatment of biological material |
08/27/1997 | EP0791592A2 Azetidines |
08/27/1997 | EP0679152B1 Anti-androgenic cyclo and bicyclo alkenes |
08/27/1997 | EP0607231B1 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |
08/27/1997 | EP0575454B1 Use of cucurbitine for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergic composition and method involving application thereof |
08/27/1997 | EP0520005B1 Nitroxides for weight reduction |
08/27/1997 | CN1157818A 1 alpha, 26-dihydroxy-D-homo-vitamin D3 |
08/27/1997 | CN1157739A A new type scald ointment |
08/26/1997 | US5661187 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals |
08/26/1997 | US5661173 Administering an enzyme inhibitor treating diabetes |
08/26/1997 | US5661140 Treating psoriasis |
08/26/1997 | US5661135 Human VEGF-specific oligonucleotides |